Unfolding and breakdown of insulin in the presence of endogenous thiols  by Jiang, Chuantao & Chang, Jui-Yoa
FEBS 29715 FEBS Letters 579 (2005) 3927–3931Unfolding and breakdown of insulin in the presence of endogenous thiols
Chuantao Jiang, Jui-Yoa Chang*
Center for Protein Chemistry, Brown Foundation Institute of Molecular Medicine for the Prevention of Human Diseases,
The University of Texas, Houston, TX 77030, United States
Received 30 March 2005; revised 5 May 2005; accepted 3 June 2005
Available online 20 June 2005
Edited by Christian GriesingerAbstract Native insulin denatures and unfolds in the presence
of thiol catalyst via disulﬁde scrambling (isomerization). It
undergoes two transient non-native conformational isomers, fol-
lowed by an irreversible breakdown of the protein to form oxi-
dized A- and B-chain. Denaturation and breakdown of native
insulin may occur under physiological conditions. At 37 C, pH
7.4, and in the presence of cysteine (0.2 mM), native insulin
decomposes with a pseudo ﬁrst order kinetic of 0.075 h1. At
50 C, the rate increases by 5-fold. GdnCl and urea induced
denaturation of insulin follows the same mechanism. These re-
sults demonstrate that stability and unfolding pathway of insulin
in the presence of endogenous thiol diﬀer fundamentally from its
reversible denaturation observed in the absence of thiol, in which
native disulﬁde bonds of insulin were kept intact during the pro-
cess of denaturation.
 2005 Published by Elsevier B.V. on behalf of the Federation of
European Biochemical Societies.
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Structure of denatured insulin1. Introduction
Insulin is a globular protein comprising two polypeptides,
A-chain (21 residues) and B-chain (30 residues), cross-linked
by three native disulﬁde bonds [1]. It is generated in vivo via
proteolytic processing of a single chain precursor, proinsulin
[2,3]. Insulin was the ﬁrst protein produced by recombinant
DNA technology for therapeutic application [4]. As one of
the best characterized and most widely used therapeutic pro-
teins, the data of insulin stability is of prime importance with
respect to its structure–function, its formulation and adminis-
tration. The covalent stability [5–7], polymerization [8,9],
aggregation [10,11] and ﬁbril formation [12–16] of insulin have
been investigated most extensively. The conformational stabil-
ity of insulin has also been studied by diﬀerent laboratories
[17–21]. Many of these data were obtained at diﬀerent pH or
salt concentrations or in the presence of an organic co-solventAbbreviations: HPLC, high performance liquid chromatography;
GdnCl, guanidine hydrochloride; Cys, cysteine; GSH, reduced gluta-
thione; GSSG, oxidized glutathione; TFA, triﬂuoroacetic acid
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doi:10.1016/j.febslet.2005.06.010and most investigations were conducted by the ‘‘disulﬁde
intact’’ denaturation, in which the network of native disulﬁde
bonds of insulin were kept intact during the process of
denaturation.
Our laboratory has recently shown that conformational sta-
bility of a disulﬁde protein may decrease signiﬁcantly in the
presence of catalytic amount of free thiols, including endoge-
nous amino-thiols (e.g., cystein (Cys) and reduced glutathione
(GSH)) [22]. Under these conditions, the rigid network of na-
tive disulﬁde bonds is rendered ﬂexible and denaturation of the
protein is escorted by ‘‘disulﬁde scrambling’’ (disulﬁde isomer-
ization) according to the conformation induced by the dena-
turant [23,24]. The denaturation results in the formation of a
mixture of heterogeneous scrambled isomers, which are acid-
stable can be trapped in acid, analyzed by high performance
liquid chromatography (HPLC) and quantiﬁed with accuracy
[24]. The extent of denaturation inﬂicted by the denaturant is
directly reﬂected by the extent of conversion of the native pro-
tein to the scrambled isomers. For instance, the conforma-
tional stability of bovine pancreatic phospholipase A2,
D(DGH20), is reduced by 6.2 kcal/mol when disulﬁde isomeriza-
tion is allowed in the presence of thiol catalyst [22]. This phe-
nomenon has been similarly observed in the cases of
ribonuclease A [25,26] and a-lactalbumin [24,27].
Using the technique of ‘‘disulﬁde scrambling’’ denaturation,
we have revisited the conformational stability of bovine insulin
in the presence of endogenous thiols. The results show that
denaturation of native insulin undergoes two previously iden-
tiﬁed conformational isomers and leads to an irreversible
breakdown of the protein. It is demonstrated here that unfold-
ing and breakdown of a signiﬁcant fraction of native insulin
may occur even at physiological pH, temperature and in the
presence of physiological concentration of endogenous thiol.2. Materials and methods
2.1. Materials
Bovine pancreatic insulin (I-5500) was obtained from Sigma. The
protein was re-puriﬁed by HPLC with a ﬁnal purity of greater than
99.8%. Cysteine, reduced and oxidized glutathione, urea and guanidine
hydrochloride (GdnCl) were also purchased from Sigma, all with pur-
ity greater than 99.5%. Human serum was obtained from one of the
authors (C.T. Jiang).
2.2. Denaturation of the native insulin in the presence of thiols
For thermal denaturation, the native insulin (0.5 mg/ml) was dis-
solved in the phosphate buﬀer (20 mM, pH 7.4, 100 mM NaCl) con-
taining diﬀerent concentrations of Cys (15, 50 and 200 lM) or
GSH (50 and 200 lM). Denaturation was carried out at 37 and
50 C for up to 24 h. In the cases of chemical denaturation, the nativeation of European Biochemical Societies.
Fig. 1. Thermal denaturation of insulin in the presence of endogenous
thiol. Insulin was incubated in phosphate buﬀer (20 mM, pH 7.4,
0.1 MNaCl) containing 200 lMof Cys. The protein concentration was
25 lg/50 ll. Denaturation was carried out at 37 and 50 C for up to
24 h. Time-course incubated samples were quenched by acidiﬁcation
and analyzed by HPLC using the conditions described in the text. The
decrease of native insulin (N) is accompanied by the appearance of two
transient intermediates (c and d) which are isomers of N, followed by
the increase of three fractions of end products (a1, a2 and b) which are
oxidized insulin A- and B-chain.
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7.4) containing Cys (200 lM) and selected concentrations of urea
and GdnCl. Denaturation was carried out at 22 C for up to 24 h.
To monitor the kinetics and intermediates of unfolding, aliquots of
insulin sample were removed at diﬀerent time points, quenched with
an equal volume of 4% aqueous triﬂuoroacetic acid (TFA) and ana-
lyzed by reversed-phase HPLC.
2.3. Denaturation of insulin in human serum
Native insulin (0.5 mg/ml) was dissolved in an undiluted human ser-
um. The serum samples were incubated at 37 and 50 C for a time per-
iod up to 8 h. A serum sample without inclusion of insulin was
processed as the control. Denatured insulin was quenched in a time-
course manner by mixing aliquots of reaction samples with a double
volume of 4% aqueous TFA, kept at room temperature for 30 min, fol-
lowed by centrifugation at 16000 · g for 10 min. The supernatant was
ﬁltered by passing through a 0.2 lm PVDF syringe ﬁlter (4 mm diam-
eter). The ﬁltrate was then directly analyzed by HPLC.
2.4. HPLC analysis of the denatured products of insulin
Denatured insulin samples were analyzed by HPLC using the follow-
ing conditions. Column was Zorbax 300XB-C18, 250 mm · 4.6 mm
5 lm. Buﬀer A was 0.1% TFA in water. Buﬀer B was 0.086% TFA
in acetonitrile/water (9:1, by volume). The gradient of elution was
20% B to 70% B linear in 40 min. The ﬂow rate was 0.5 ml/min. Col-
umn temperature was 22 C.
2.5. Chemical modiﬁcation of the denatured products of insulin
Fractions of denatured insulin (20 lg) were isolated, freeze-dried
and modiﬁed with vinylpyridine (5 ll) or iodoacetic acid (0.1 M) in
50 ll of Tris–HCl buﬀer (0.1 M, pH 8.4). Reactions were allowed at
23 C for 45 min, acidiﬁed with an equal volume of 4% aqueous
TFA, and analyzed by RP-HPLC and MALDI-TOF.
2.6. Mass spectrometry analysis of the denatured products of insulin
The molecular mass of denatured products of insulin, both unmod-
iﬁed and those modiﬁed with vinylpyridine and iodoacetic acid, were
determined by MALDI-TOF mass spectrometer (Perkin–Elmer Voy-
ager-DE STR) using 2,5-dihydroxybenzoic acid as matrix. Molecular
mass of analyzed peptides were calibrated by the following standards.
Bradykinin fragment (residues 1–7) (MH+ 757.3997); Synthetic peptide
P14R (MH+ 1533.8582) and ACTH fragment (residues 18–39) (MH+
2465.1989).3. Results
3.1. Thermal denaturation of native insulin
Thermal denaturation of insulin was performed in the buﬀer
(pH 7.4) containing Cys (0.2 mM) at both 37 and 50 C for up
to 24 h. Acid trapped samples were analyzed by HPLC. The re-
sults, given in Fig. 1, show that decrease of the native insulin,
was accompanied by the appearance of two minor transient
intermediates (fractions c and d), followed by the emergence
of three major products (denoted as a1, a2 and b). Time-course
denatured intermediates were also trapped by either vinylpyri-
dine or iodoacetic acid and analyzed by the same HPLC sys-
tem. The results are indistinguishable from the acid trapped
sample shown in Fig. 1, suggesting that all ﬁve fractions of
denatured insulin exist in oxidized form and none of them con-
tains free cysteine. GSH catalyzed thermal denaturation of
insulin follows the same unfolding pathway.
Fractions a1, a2, b, c, and d were isolated and analyzed by
MALDI-mass spectrometry. Their observed molecular mass
indicates that a1 (2336) and a2 (2336) are 2-disulﬁde isomers
of A-chain (note that A-chain comprises two disulﬁde bonds
and may potentially adopt three 2-disulﬁde isomers). Fraction
b (3397) contains insulin B-chain with a disulﬁde bond linkingCysB7 and CysB19. Fractions c and d both exhibit molecular
mass (5733) identical to that of native insulin, suggesting that
they are non-native conformational isomers of intact insulin.
The HPLC proﬁle of fractions c and d are compatible with
the two disulﬁde isomers of human insulin, designated as insu-
lin-swap1 and insulin-swap2, identiﬁed previously [20,28,29].
Structures, stability and functions of these two insulin isomers
have been well characterized by Weiss and co-workers [20,29].
Thermal denaturation of insulin results in an irreversible
breakdown of the protein. At physiological pH, 37 C and in
the presence of Cys (0.2 mM), native insulin decomposes with
a pseudo-ﬁrst order kinetics of 0.075 h1. The rate of insulin
breakdown increases by about 5-fold at 50 C and decreases
by 3.5-fold when a lower concentration of Cys (50 lM) was ap-
plied (Fig. 2). GSH is less eﬀective than Cys in catalyzing disul-
ﬁde isomerization of insulin, noticeably at 37 C. The
simultaneous presence of GSH/GSSHG (molar ratio 2:1), a
condition that mimics the cellular environment, is also capable
of promoting thermal denaturation of insulin.
3.2. GdnCl and urea denaturation of native insulin
Chemical denaturation of insulin was performed in the Tris–
HCl buﬀer (pH 7.4) containing Cys (0.2 mM). The pathway of
GdnCl and urea induced denaturation of insulin is shown to be
indistinguishable from that of thermal denaturation. Unfold-
ing of native insulin also undergoes two minor transitory
intermediates, c and d, and ends-up with an irreparable break-
down of the protein to form the oxidized A- and B-chain (Fig.
3). In term of potency in denaturing insulin (measured by
kinetics of denaturation), 3 M of GdnCl is roughly equivalent
to 50 C, with a pseudo-ﬁrst order kinetic of 0.375 h1 (Fig.
4A). 37 C is as eﬀective as 1 M GdmCl or 2 M urea. The po-
tency of GdnCl is about 2-fold greater than urea as expected
(Fig. 4B).
Fig. 2. Kinetics of thermal denaturation of insulin at diﬀerent concentrations of Cys and GSH. Denaturation was carried out at 37 and 50 C in PBS
buﬀer (pH 7.4) containing diﬀerent concentration of cysteine (15, 50 and 200 lM), GSH (50 and 200 lM) and a combination of GSH/GSSG (200/
100 lM). Time-course denatured samples were trapped by acidiﬁcation and analyzed by HPLC to quantify the extent of denaturation. The data has a
standard deviation of ±5%.
Fig. 3. GdnCl denaturation of insulin in the presence of endogenous
thiol. Insulin was incubated in Tris–HCl buﬀer (0.1 M, pH 7.4)
containing 200 lM of Cys and selected concentrations of GdnCl. The
protein concentration was 25 lg/50 ll. Denaturation was carried out at
22 C for 6 h. Denatured samples were quenched by acidiﬁcation and
analyzed by HPLC. Five fractions of denatured insulin are speciﬁed in
Fig. 1.
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In order to assess whether thermal and irreversible denatur-
ation of insulin may potentially take place in vivo, native insu-
lin was incubated in an undiluted human serum without any
supplementing thiol. Incubation was carried out at 37 and
50 C. Samples were trapped, puriﬁed and analyzed by HPLC(Fig. 5). Denaturation of insulin is minor at 37 C. Only 1.5%
of decomposed B-chain was detected after 2 h of incubation.
This slow denaturation is presumably due to the low concen-
tration of free thiols available in human serum, which totals
about 10–15 lM, including predominant cysteine and reduced
glutathione [30]. The results nonetheless are consistent with
those performed in PBS using 15 lM of Cys as the catalyst
(Fig. 2). At elevated temperature (50 C), breakdown of native
insulin is signiﬁcant and the mechanism appears to be more
complicated. Only 45% of the total insulin was recovered after
4 h of incubation, among them, decomposed insulin accounts
for 24% of the recovered protein. The decrease of total insulin
is likely due to the protein degradation by serum proteases.4. Discussion
4.1. Unfolding pathway of insulin in the presence of thiol
Disulﬁde containing proteins may undergo reversible con-
version between the native and non-native (scrambled) isomers
in the presence of catalytic thiol via disulﬁde isomerization
[23,24,31]. This phenomenon is generally applied to single
chain proteins. With proteins comprising multiple polypep-
tides bridged by disulﬁde bonds, disulﬁde isomerization may
lead to the irreversible breakdown of the protein [32]. This is
the case observed here with insulin. Denaturation of insulin
in the presence of thiol undergoes two transient, non-native
conformational isomers as unfolding intermediates. Further
unfolding eventually results in the breakdown of these two
meta-stable intermediates and the separation of A- and B-
Fig. 5. Denaturation of native insulin in human serum. Native insulin
(25 lg/50 ll) was incubated in the undiluted human serum for the
indicated temperature and time periods. Samples were then acidiﬁed
and centrifuged to remove the mass of serum protein and analyzed by
HPLC using the same conditions described in Fig. 1. A major fraction
marked by star is derived form serum. Control sample represents
practically the 0-time sample. Numbers given in the parenthesis
indicate the extent (%) of insulin denaturation.
Fig. 4. Kinetics of chemical denaturation of insulin by GdnCl and
urea. (A) Time-course denaturation of insulin by 3 and 6 M GdnCl.
Denaturation was carried out at 22 C in Tris–HCl buﬀer, pH7.4
containing 0.2 mM Cys. Intermediates of denaturation were trapped
by acidiﬁcation and analyzed by HPLC to quantify the extent of
denaturation. (B) Denaturation of insulin by diﬀerent concentrations
of Urea and GdnCl. Denaturation was carried out at 22 C in Tris–
HCl buﬀer, pH 7.4 containing 0.2 mM Cys for 6 h. Denatured samples
were trapped by acidiﬁcation and analyzed by HPLC.
3930 C. Jiang, J.-Y. Chang / FEBS Letters 579 (2005) 3927–3931chain, both were recovered in oxidized form. This is the case
for both thermal and chemical denaturation. Properties of
these two transient unfolding intermediates, as judged from
their HPLC proﬁle, are consistent with the two isomers, desig-
nated as insulin-swap1 [A7–A11, A6–B7, A20–B19] and insu-
lin-swap2 [A6–A7, A11–B7, A20–B19], previously prepared
by direct chemical synthesis [28] and characterized in details
by NMR [29]. Insulin-swap2 is less ordered than insulin-swap1,
both retain partial native-like structure and biological activity
exhibited by the native insulin [20,29].
The pathways (and end-products) of thermal and chemical
denaturation of insulin are shown to be indistinguishable in
this study. Speciﬁcally, the concentrations of two transient
intermediates, namely ‘‘c’’ and ‘‘d’’ (Figs. 1 and 3), appeared
along the unfolding pathways are very similar. This is not al-
ways the case with other proteins, with which partially un-
folded intermediates tend to accumulate during the thermal
denaturation. One distinct example is a-lactalbumin [24].
Chemical denaturation converts native a-lactalbumin to form
extensively unfolded isomers via heterogeneous intermediates.
By contrast, a partially unfolded isomer of a-lactalbumin
exhibiting characteristics of molten globule has been shown
to be the major product of heat denatured a-lactalbumin [24].4.2. Stability of insulin in the presence of thiol
The conformational structure of insulin becomes more sus-
ceptible to denaturation in the presence of thiol catalyst. The
vulnerability is shown to be dependent on the concentration
of thiol catalyst. However, stability of insulin in the absence
and presence thiol catalyst cannot be compared directly be-
cause the mechanisms of insulin denaturation under these
two conditions are fundamentally diﬀerent. In the absence of
thiol, native disulﬁde bonds are kept intact and denaturation
of insulin is reversible [17–21]. Stability of insulin is thus mea-
sured in a thermodynamic fashion. The midpoint of denatur-
ation curve [GdnCl]1/2of native insulin is 5–5.5 M, with a
conformational stability (DGu) estimated to be 4.4 kcal/mol
[20]. This would rank the stability of native insulin in the range
comparable to that of bovine phospholipase A2 [22]. In the
presence of thiol, native disulﬁde bonds are ﬂexible and al-
lowed to isomerize, and denaturation of insulin is practically
irreversible. Under these conditions, stability of insulin is mea-
sured by the kinetics of decrease of the native structure. We
have shown that even at physiological temperature and given
an eﬀective dose of thiol catalyst, native insulin may undergo
thermal denaturation with a ﬁrst order kinetics of 0.075 h1.
At 5 M GdnCl and room temperature, irreversible denatur-
ation of insulin is near quantitative within 5 h.
4.3. Denaturation of insulin in biological milieu
The ﬁnding that native insulin may suﬀer partial denatur-
ation in the presence of thiol catalyst at physiological pH
and temperature implies that it might similarly occur in vivo.
The scenario that a disulﬁde protein, like insulin, may denature
in a given biological milieu via disulﬁde scrambling is persua-
sive because endogenous thiols exist in most biological envi-
ronments. Majority of disulﬁde containing proteins are
secretory. The redox state of secretory pathway, in which
disulﬁde proteins undergo folding, transportation and secre-
tion, consists of reduced and oxidized glutathione (GSH/
GSSG) with molar ratio ranging from 1:1 to 3:1. The overall
cellular environment is highly reductive and its GSH/GSSG ra-
tio ranges from 30:1 to 100:1 [33]. The disulﬁde-intact dena-
turation seems to be more appropriate under more oxidizing
conditions but it has to be borne in mind that once these
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catalytic amounts of a thiol can promote disulﬁde shuﬄing
and may drastically alter their conformational stability.
In human serum, the endogenous amino-thiols comprise pri-
marily Cys, CysGly and glutathione and exist predominantly
in oxidized form [30]. The ratio of reduced to oxidized
amino-thiols ranges from 0.13 for Cys (7.2 lM Cys/55 lM
Cys-Cys) to 0.26 for CysGly (2.8 lM CysGly/10.7 lM Cys-
Gly-CysGly) to 1.5 for glutathione (2.1 lM GSH/1.4 lM
GSSG). Even in this environment, denaturation of insulin
has been detected at physiological temperature, with a decom-
position rate of 4 · 103 h1.
It is relevant to point out that in the in vivo circulatory sys-
tem, the half-life of insulin is about 5–6 min [34,35]. Thus the
mechanism of insulin breakdown demonstrated in this study
may account for only a small fraction of insulin clearance ob-
served in vivo, in which insulin is metabolized and processed
by far a far more complex mechanism.
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